Advertisement

Apoptosis pp 72-86 | Cite as

bcl-2: Antidote for Cell Death

  • Y. Tsujimoto
Part of the Progress in Molecular and Subcellular Biology book series (PMSB, volume 16)

Abstract

The bcl-2 proto-oncogene, originally identified through the study of the t(14;18) translocation present in human B-cell follicular lymphomas, is unique among oncogenes in its ability to enhance cell survival by interfering with apoptotic cell death. This finding provided the important notion to the cancer research field that inhibition of cell death might be a critical step in tumorigenesis. This idea was supported by the demonstration that several cancer genes, including oncogenes and anti-oncogenes, have activities to modulate the apoptotic process, bcl-2 exerts a death-sparing activity against apoptosis induced by a wide variety of stimuli and, therefore, appears to function at a critical step in a common process in which several different apoptotic signals converge, although the mechanism of bcl-2 function remains unknown, bcl-2 has recently been recognized as a member of a family through the discovery of many structually related genes, some of which function like bcl-2 while others inhibit the death-sparing function of bcl-2 or other members. Detailed analysis of the bcl-2 family members will provide important clues toward an understanding of the molecular basis of apoptotic cell death. Here, current information on the bcl-2 gene and other members of this family is reviewed.

Keywords

Apoptotic Cell Death Follicular Lymphoma African Swine Fever Virus Nuclear Outer Membrane Human Follicular Lymphoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Akao Y, Ohtsuki Y, Kataoka S, Ito Y, Tsujimoto Y (1994) Multiple subcellular localization of bcl-2: detection in nuclear outer membrane, endoplasmic reticulum and mitochondrial inner and outer membranes. Cancer Res 54: 2468–2471PubMedGoogle Scholar
  2. Allsopp TE, Wyatt S, Paterson HF, Davies AM (1993) The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell 73: 295–307PubMedCrossRefGoogle Scholar
  3. Alnemri ES, Robertson NM, Fernandes TF, Croce CM, Litwack G (1992) Overexpressed full-length human bcl-2 extends the survival of baculovirus-infected Sf9 insect cells. Proc Natl Acad Sci USA 89: 7295–7299PubMedCrossRefGoogle Scholar
  4. Baffy G, Miyashita T, Williamson JR, Reed JC (1993) Apoptosis induced by withdrawal of interleukin-3 (IL-3) from an IL-3-dependent hematopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced bcl-2 oncoprotein production. J Biol Chem 268: 6511–6519PubMedGoogle Scholar
  5. Bakhshi A, Jensen JP, Goldman P, Wright JJ, McBride OW, Epstein AL, Korsmeyer SJ (1985) Cloning the chromosomal breakpoint of t(14; 18) human lymphoma: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 41: 889–906CrossRefGoogle Scholar
  6. Bissonnette RP, Echeverri F, Mahboubi A, Green DR (1992) Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359: 552–554PubMedCrossRefGoogle Scholar
  7. Blackman M, Kappler J, Marrack P (1990) The role of the T cell receptor in positive and negative selection of developing T cells. Science 248: 1335–1338PubMedCrossRefGoogle Scholar
  8. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB (1993) bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597–608PubMedCrossRefGoogle Scholar
  9. Borzillo GV, Endo K, Tsujimoto Y (1992) Bcl-2 confers growth and survival advantage to IL-7-dependent early pre-B cells which become factor-independent by a multiple process in culture. Oncogene 7: 869–876PubMedGoogle Scholar
  10. Boyd JM, Malstrom S, Subramanian T, Venkatesh LK, Schaeper U, Elangovan B, D’Sa-Eipper C, Chinnadurai G (1994) Adenovirus E1B 19kDa and bcl-2 proteins interact with a common set of cellular proteins. Cell 79: 341–351PubMedCrossRefGoogle Scholar
  11. Buttke TM, Sandstrom PA (1994) Oxidative stress as a mediator of apoptosis. Immunol Today 7: 7–10CrossRefGoogle Scholar
  12. Chen-Levy Z, Cleary ML (1990) Membrane topology of the bcl-2 proto-oncogene protein demonstrated in vitro. J Biol Chem 265: 4929–4933PubMedGoogle Scholar
  13. Chen-Levy Z, Nourse J, Cleary ML (1989) The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral membrane protein highly expressed in lymphoid cell lines and lymphoma carrying the t(14; 18) translocation. Mol Cell Biol 9: 701–710PubMedGoogle Scholar
  14. Chittenden T, Harrington EA, O’Connor R, Flemington C, Lutz RJ, Evan GI, Guild BC (1995) Induction of apoptosis by the bcl-2 homologue bak. Nature 374: 733–736PubMedCrossRefGoogle Scholar
  15. Cleary ML, Sklar J (1985) Nucleotide sequence of at (14; 8) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA 81: 593–597CrossRefGoogle Scholar
  16. Croce CM (1987) Role of chromosome translocations in human neoplasia. Cell 49: 155–156PubMedCrossRefGoogle Scholar
  17. Dubois-Dauphin M, Frankowski H, Tsujimoto Y, Huarte J, Martinou J-C (1994) Neonatal motoneurons overexpressing the bcl-2 protooncogene in transgenic mice are protected from axotomy-induced cell death. Proc Natl Acad Sci USA 91: 3309–3313PubMedCrossRefGoogle Scholar
  18. Eguchi Y, Ewert DL, Tsujimoto Y (1992) Isolation and characterization of the chicken bcl-2 gene: expression in a variety of tissues including lymphoid and neuronal organs in adult and embryo. Nucl Acid Res 20: 4187–4192CrossRefGoogle Scholar
  19. Fanvini A, Harrington EA, Evan GI (1992) Cooperative interaction between c-myc and bcl-2 protooncogenes. Nature 359: 554–556CrossRefGoogle Scholar
  20. Farrow SN, White JH, Martinou I, Raven T, Pun K-T, Grinham CJ, Martinou J-C, Brown R (1995) Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19 K. Nature 374: 731–733PubMedCrossRefGoogle Scholar
  21. Fernandez-Sarabia MJ, Bischoff JR (1993) bcl-2 associates with the ras-related protein R-ras p23. Nature 366: 274–275PubMedCrossRefGoogle Scholar
  22. Gagliardini V, Fernandez P-A, Lee RKK, Drexler CA, Rotello RJ, Fishman MC, Yuan J (1994) Prevention of vertebrate neuronal death by the crmA gene. Science 263: 826–828PubMedCrossRefGoogle Scholar
  23. Garcia I, Martinou I, Tsujimoto Y, Martinou J-C (1992) Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science 258: 302–304PubMedCrossRefGoogle Scholar
  24. Gonzalez-Garcia M, Perez-Ballestero R, Ding L, Duan L, Boise LH, Thompson CB, Nunez G (1994) bcl-xL is the major bcl-x mRNA form expressed during murine development and its product localizes to mitochondria. Development 120: 3033–3042PubMedGoogle Scholar
  25. Hartley SB, Cooke MP, Fulcher DA, Harris AW, Cory S, Basten A, Goodnow CC (1993) Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell 72: 325–335PubMedCrossRefGoogle Scholar
  26. Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Iongnecker R, Kieff E, Rickinson D (1991) Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65: 1107–1115PubMedCrossRefGoogle Scholar
  27. Hengartner MO, Ellis R, Horvitz R (1992) Caenorhabditid elegans gene ced-9 protects cells from programmed cell death. Nature 356: 494–499PubMedCrossRefGoogle Scholar
  28. Hengartner MO, Hortvitz HR (1994) C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell 70: 665–676CrossRefGoogle Scholar
  29. Hockenbery D, Nunez G, Milliman C, Schreber RD, Korsmeyer SJ (1990) bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334–336PubMedCrossRefGoogle Scholar
  30. Hockenbery DM, Zutter M, Hickey W, Moon N, Korsmeyer SJ (1991) bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 88: 6961–6965PubMedCrossRefGoogle Scholar
  31. Hockenbery DM, Oltvai ZN, Yin X-M, Milliman CL, Korsmeyer SJ (1993) bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75: 241–251PubMedCrossRefGoogle Scholar
  32. Jacobson MD, Burne JF, King MP, Miyashita T, Reed JC, Raff MC (1993) bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 361: 365–369PubMedCrossRefGoogle Scholar
  33. Jacobson MD, Raff MC (1995) Programmed cell death and bcl-2 protection in very low oxygen. Nature 374: 814–816PubMedCrossRefGoogle Scholar
  34. Kamada S, Shimono A, Shinto Y, Tsujimura T, Takahashi T, Noda T, Kitamura Y, Kondoh H, Tsujimoto Y (1995) Bcl-2 deficiency in mice leads to pleiotropic abnormalities: accelerated lymphoid cell death in thymus and spleen, polycystic kidney, hair hypopigmentation and distorted small intestine. Cancer Res 55: 354–359PubMedGoogle Scholar
  35. Kane DJ, Sarafian TA, Anton R, Hahn H, Gralla EB, Valentine JS, Ord T, Bredesen DE (1993) bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262: 1274–1277PubMedCrossRefGoogle Scholar
  36. Katsumata M, Siegel RM, Louie DC, Miyashita T, Tsujimoto Y, Nowell PC, Green MI, Reed JC (1992) Differential effects of bcl-2 on T and B cells in transgenic mice. Proc Natl Acad Sci USA 89: 11376–11380PubMedCrossRefGoogle Scholar
  37. Kiefer MC, Brauer MJ, Powers VC, Wu JJ, Umansky SR, Tomei LD, Barr PJ (1995) Modulation of apoptosis by the widely distributed bcl-2 homologue bak. Nature 374: 736–739PubMedCrossRefGoogle Scholar
  38. Kozopas KM, Yang T, Buchan HL, Zhou P, Craig RW (1993) Mcl-1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to bcl-2. Proc Natl Acad Sci USA 90: 3516–3520PubMedCrossRefGoogle Scholar
  39. Krajewski S, Tanaka S, Takayama S, Schibier MJ, Fenton W, Reed JC (1993) Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res 53: 4701–4714PubMedGoogle Scholar
  40. Lam M, Dubyak G, Chen L, Nunez G, Miesfeld RL, Distelhost CW (1994) Evidence that bcl-2 represses apoptosis by regulating endoplasmic reticulum-associated Ca2+ fluxes. Proc Natl Acad Sci USA 91: 6569–6573PubMedCrossRefGoogle Scholar
  41. Levine B, Huang Q, Isaacs JT, Reed JC, Griffin DE, Hardwick JM (1993) Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. Nature 361: 739–742PubMedCrossRefGoogle Scholar
  42. LeBrun DP, Warnke RA, Cleary ML (1993) Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. Am J Pathol 142: 743–753PubMedGoogle Scholar
  43. Lin EY, Orlofsky A, Berger MS, Prystowsky MB (1993) Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2. J Immunol 151: 1979–1988PubMedGoogle Scholar
  44. Liu Y-J, Mason DY, Johnson GD, Abbot S, Gregory CD, Hardie DL, Gordon J, MacLennan ICM (1991) Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur J Immunol 21: 1905–1910PubMedCrossRefGoogle Scholar
  45. Lu Q-L, Poulsom R, Wong L, Hanby AM (1993) Bcl-2 expression in adult and embryonic non-haematopoietic tissues. J Pathol 169: 431–437PubMedCrossRefGoogle Scholar
  46. Mansour S, Thomas KR, Capecchi MR (1988) Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature 336: 348–352PubMedCrossRefGoogle Scholar
  47. Martinou J-C, Dubois-Dauohin M, Staple JK, Rodriguez I, Frankowski H, Missotten M, Albertini P, Talabot D, Catsicas S, Pietra C, Huarte J (1994) Overexpression of bcl-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 13: 1017–1030PubMedCrossRefGoogle Scholar
  48. McDonnell TJ, Deane N, Platt FM, Nunez G, Jaeger U, McKeam JP, Korsmeyer SJ (1989) bcl-2- immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lympho-proliferation. Cell 57: 79–88PubMedCrossRefGoogle Scholar
  49. McDonnell TJ, Korsmeyer SJ (1991) Progression from lympoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18). Nature 349: 254–256PubMedCrossRefGoogle Scholar
  50. Monaghan P, Robertson D, Amos TAS, Dyer MJS, Mason DY, Greaves MF (1992) Ultrastructural localization of bcl-2 protein. J Histochem Cytochem 40: 1819–1825PubMedCrossRefGoogle Scholar
  51. Nakayama K-I, Nakayama K, Negishi I, Kuida K, Shinkai Y, Louie MC, Fields LE, Lucas PJ, Stewart V, Alt FW, Loh DY (1993) Disappearance of the lymphoid system in bcl-2 homozygous mutant chimeric mice. Science 261: 1584–1587PubMedCrossRefGoogle Scholar
  52. Nakayama K, Nakayama K-I, Negishi I, Kuida K, Sawa H, Loh DY (1994) Targeted disruption of bcl-2αβ in mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Proc Natl Acad Sci USA 91: 3700–3704PubMedCrossRefGoogle Scholar
  53. Neilan JG, Lu Z, Afonso CL, Kutish GF, Sussman MD, Rock DL (1993) An African swine fever virus gene with similarity to the protooncogene bcl-2 and the Epstein-Barr virus gene BHRF1. J Virol 67: 4391–4394PubMedGoogle Scholar
  54. Negrini M, Silini E, Kozak C, Tsujimoto Y, Croce CM (1987) Molecular analysis of mbcl-2: structure and expression of the murine gene homologous to the human gene involved in follicular lymphoma. Cell 49: 455–463PubMedCrossRefGoogle Scholar
  55. Novack DV, Korsemeyer SJ (1994) Bcl-2 protein expression during murine development. Am J Pathol 145: 61–73PubMedGoogle Scholar
  56. Nunez G, Seto M, Seremetis S, Ferrero D, Grignani F, Korsmeyer SJ, Dalla-Favera R (1989) Growth- and tumor-promoting effects of deregulated bcl-2 in human B-lymphoblastoid cells. Proc Natl Acad Sci USA 86: 4589–1593PubMedCrossRefGoogle Scholar
  57. Nunez G, London L, Hockenbery D, Alexander M, McKearn JP, Korsmeyer SJ (1990) Deregulated bcl-2 gene expression selectively prolongs survival of growth factor-deprived hematopoietic cell lines. J Immunol 144: 3602–3610PubMedGoogle Scholar
  58. Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 74: 609–619PubMedCrossRefGoogle Scholar
  59. Pearson GR, Luka J, Petti L, Sample M, Birkenback M, Braun D, Kieff E (1987) Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex. Virology 160: 151–161PubMedCrossRefGoogle Scholar
  60. Pezzella F, Tse AGD, Cordell JL, Pulford KAF, Gatter KC, Mason DY (1990) Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Am J Pathol 137: 225–232PubMedGoogle Scholar
  61. Ray CA, Black RA, Kronheim SR, Greenstreet TA, Sleath PR, Salvesen GS, Pickup DJ (1992) Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme. Cell 69: 597–604PubMedCrossRefGoogle Scholar
  62. Reed JC, Haidar S, Cuddy MP, Croce CM, Makover D (1989) Deregulated bcl-2 expression enhances growth of a human B cell line. Oncogene 4: 1123–1127PubMedGoogle Scholar
  63. Reynolds JE, Yang T, Qian L, Jenkinson JD, Zhou P, Eastman A, Craig RW (1994) Mcl-1, a member of the bcl-2 family, delays apoptosis by c-myc overexpression in Chinese hamster ovary cells. Cancer Res 54: 6348–6352PubMedGoogle Scholar
  64. Sato T, Hanada M, Bodrug S, Irie S, Iwama N, Boise LH, Thompson CB, Golemis E, Fong L, Wang H-G, Reed JC (1994) Interaction among members of the bcl-2 protein family analyzed with a yeast two-hybrid system. Proc Natl Acad Sci USA 91: 9238–9242PubMedCrossRefGoogle Scholar
  65. Sentman CL, Shutter JR, Hockenbery D, Kanagawa O, Korsmeyer SJ (1991) bcl-2 inhibits multiple forms of apoptosis but not negative selection of thymocytes. Cell 67: 879–888PubMedCrossRefGoogle Scholar
  66. Seto M, Jaeger U, Hockett RD, Graninger W, Bennett S, Goldman P, Korsmeyer SJ (1988) Alternative promoters and exons, somatic mutations and deregulation of the bcl-2-Ig fusion gene in lymphoma. EMBO J 7: 123–131PubMedGoogle Scholar
  67. Shimizu S, Eguchi Y, Kosaka H, Kamiike W, Matsuda H, Tsujimoto Y (1995) Prevention of hypoxia-induced cell death by bcl-2 and bcl-xL. Nature 374: 811–813PubMedCrossRefGoogle Scholar
  68. Strasser A, Harris AW, Bath M, Cory S (1990) Novel primitive lymphoid tumors induced in transgenic mice by cooperation between myc and bcl-2. Nature 348: 331–333PubMedCrossRefGoogle Scholar
  69. Strasser A, Harris AW, Cory S (1991a) bcl-2 transgene inhibits T cell death and perturbs thymic selfcensorship. Cell 67: 889–899PubMedCrossRefGoogle Scholar
  70. Strasser A, Whittingham S, Vaux DL, Bath ML, Adams JM, Cory S, Harris A (1991b) Enforced bcl-2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci USA 88: 8661–8665PubMedCrossRefGoogle Scholar
  71. Strasser A, Harris AW, Vaux DL, Webb E, Bath ML, Elefanty AG, Adams JM, Cory S (1992) The role of bcl-2 in lymphoid differentiation and neoplastic transformation. Curr Top Microbiol Immunol 182: 299–302PubMedGoogle Scholar
  72. Strasser A, Harris AW, Cory S (1993) Eμ-bcl-2 transgene faciliates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells. Oncogene 8: 1–9PubMedGoogle Scholar
  73. Takayama S, Sato T, Krajewski S, Kochel K, Irie S, Millan JA, Reed JC (1995) Cloning and functional analysis of bag-1: a novel bcl-2-binding protein with anti-cell death activity. Cell 80: 279–284PubMedCrossRefGoogle Scholar
  74. Tsujimoto Y (1989) Overexpression of the human bcl-2 gene product results in growth enhancement of Epstein-Barr virus-immortalized B cells. Proc Natl Acad Sci USA 86: 1958–1962PubMedCrossRefGoogle Scholar
  75. Tsujimoto Y, Croce CM (1986) Analysis of the structure, transcripts and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA 83: 5214–5218PubMedCrossRefGoogle Scholar
  76. Tsujimoto Y, Cossman J, Jaffe E, Croce CM (1985) Involvement of the bcl-2 gene in human follicular lymphoma. Science 228: 1440–1443PubMedCrossRefGoogle Scholar
  77. Tsujimoto Y, Ikegaki N, Croce CM (1987) Characterization of the protein product of bcl-2, the gene involved in human follicular lymphoma. Oncogene 2: 3–7PubMedGoogle Scholar
  78. Vaux DL, Cory S, Adams JM (1988) bcl-2 gene promotes haemopoietic cell survial and cooperates with c-myc to immortalize pre-B cells. Nature 335: 440–442PubMedCrossRefGoogle Scholar
  79. Vaux DL, Weissman IL, Kim SK (1992) Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2. Science 258: 1955–1957PubMedCrossRefGoogle Scholar
  80. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ (1993) Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75: 229–240PubMedCrossRefGoogle Scholar
  81. White E, Sabbatini P, Debba M, Wold WSM, Kusher DI, Gooding LR (1992) The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor a. Mol Cell Biol 12: 2570–2580PubMedGoogle Scholar
  82. Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ (1995) Bad, a heterodimeric partner for bcl-xL and bcl-2, displaces bax and promotes cell death. Cell 80: 285–291PubMedCrossRefGoogle Scholar
  83. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR (1993) The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1/3-converting enzyme. Cell 75: 641–652PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • Y. Tsujimoto
    • 1
  1. 1.Biomedical Research Center, Dept. of Medical GeneticsOsaka University Medical SchoolSuita, OsakaJapan

Personalised recommendations